Kyle Gano, Chief Business Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 6,318 shares at $88.14 ($557K) on 2019-02-04, disclosed to the SEC on 2019-02-06.
Seasonal sale ($557k) by Chief Business Development Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.14 | 1,375 | $121K | 21.8% |
| 2 | $88.14 | 1,375 | $121K | 21.8% |
| 3 | $88.05 | 465 | $41K | 7.4% |
| 4 | $88.05 | 465 | $41K | 7.4% |
| 5 | $88.14 | 669 | $59K | 10.6% |
| 6 | $88.14 | 1,300 |
| $115K |
| 20.6% |
| 7 | $88.14 | 669 | $59K | 10.6% |
| Total | $88.12 avg | 6,318 | $557K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $598K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $471K | — | Filing → |